HIF1A and leukemia: Since the treatment of prolyl hydroxylase inhibitor is known to stabilize hypoxia-inducible factor1 alpha and previous studies showed that overexpression of HIF1α may lead to the growth arrest of leukemia cells [51], we wanted to ask whether the growth inhibitory phenotype induced by prolyl hydroxylase inhibitors is dependent on HIF1α.